This stock comparison between GS and NMR examines two prominent players in the investment banking space. Both companies provide services like mergers and acquisitions (M&A, deals where companies combine or one buys another), trading, and asset management, but differ in scale and regional focus. Traders seeking momentum plays or relative value opportunities, and investors evaluating financial sector exposure, may find value in analyzing their recent trajectories, financial metrics, and market positioning. With broader economic shifts influencing banking stocks, this review highlights key contrasts in performance and outlook.
The Goldman Sachs Group (GS) is a leading global investment bank, known for its bulge-bracket status in underwriting, trading, and wealth management. In recent market activity, GS shares have climbed over 12% in the past month, trading near $927 with a 52-week range of $531 to $985. This upward trend follows a strong Q1 2026 earnings report, where EPS reached $17.55, surpassing estimates, driven by elevated trading revenue and deal flow. Sentiment has been bolstered by strategic moves like AI investments and positive analyst views, though high valuations and legal settlements temper gains. The stock's price-to-earnings (P/E, stock price divided by earnings per share) ratio stands at about 17, reflecting robust profitability with net margins near 29%.
Nomura Holdings (NMR) is a major Japanese financial institution with global operations in investment banking, retail brokerage, and asset management. Over recent weeks, NMR shares have dipped around 2.5%, trading near $7.80 within a 52-week range of $5.45 to $9.58. Performance reflects a Q3 earnings miss with EPS of $0.20 against expectations, alongside neutral macroeconomic previews. Trading volume remains steady, but sentiment is mixed due to share buybacks and institutional interest in diversification. With a lower P/E ratio of 10.5 and dividend yield over 5%, NMR appeals for value, supported by revenue growth in recent fiscal years, though margins at 18% lag peers.
Tickeron's Trending AI Robots page showcases the top performers among its 351 AI trading bots, which collectively trade thousands of tickers across stocks, ETFs, and crypto using diverse strategies like swing trading, scalping, and sector-specific plays. Only 25 bots earn a spot in this curated section based on real-time adaptability to market conditions, featuring impressive stats such as annualized returns up to +170%, win rates from 48% to 88%, and profit factors ranging 1.5 to 6.9. Examples include semiconductor-focused bots with +104% annualized returns and 64% win rates on tickers like LRCX and NVDA, or industrials bots at +73% with 57% wins. These automated systems vary in timeframes from minutes to weeks, offering transparency on drawdowns and profit-to-drawdown ratios. Explore the page to identify bots aligning with your trading style.
GS and NMR share investment banking cores but diverge in scale and exposure: GS's U.S.-centric global franchise drives higher growth via M&A and trading, while NMR emphasizes Asia-Pacific retail and wholesale. Recent momentum favors GS with double-digit gains versus NMR's pullback, tied to earnings strength. Risk profiles contrast, with GS's higher beta amplifying sector volatility but rewarding upside, against NMR's stability. Valuation trade-offs include NMR's cheaper P/E and yield for income seekers, while GS offers superior ROE and margins for growth-oriented positioning. Market sentiment leans positive for GS amid analyst upgrades, versus NMR's value appeal.
Tickeron's AI models currently favor GS over NMR, based on consistent upward trends, earnings catalysts, and stronger relative positioning in recent weeks. Factors like elevated profitability and momentum suggest higher probability of outperformance, though NMR's lower valuation could shine in risk-off environments. This assessment draws from observable data patterns rather than forecasts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GS’s FA Score shows that 4 FA rating(s) are green whileNMR’s FA Score has 3 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GS’s TA Score shows that 3 TA indicator(s) are bullish while NMR’s TA Score has 5 bullish TA indicator(s).
GS (@Investment Banks/Brokers) experienced а +0.35% price change this week, while NMR (@Investment Banks/Brokers) price change was +2.27% for the same time period.
The average weekly price growth across all stocks in the @Investment Banks/Brokers industry was -1.94%. For the same industry, the average monthly price growth was -2.57%, and the average quarterly price growth was -6.90%.
GS is expected to report earnings on Jul 14, 2026.
NMR is expected to report earnings on Jul 29, 2026.
These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.
| GS | NMR | GS / NMR | |
| Capitalization | 323B | 25.4B | 1,272% |
| EBITDA | N/A | N/A | - |
| Gain YTD | 25.717 | 7.390 | 348% |
| P/E Ratio | 20.21 | 12.23 | 165% |
| Revenue | 60.4B | 1.8T | 3% |
| Total Cash | N/A | N/A | - |
| Total Debt | 435B | 16.6T | 3% |
GS | NMR | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 32 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 84 Overvalued | 12 Undervalued | |
PROFIT vs RISK RATING 1..100 | 6 | 34 | |
SMR RATING 1..100 | 7 | 3 | |
PRICE GROWTH RATING 1..100 | 9 | 43 | |
P/E GROWTH RATING 1..100 | 27 | 19 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NMR's Valuation (12) in the Investment Banks Or Brokers industry is significantly better than the same rating for GS (84). This means that NMR’s stock grew significantly faster than GS’s over the last 12 months.
GS's Profit vs Risk Rating (6) in the Investment Banks Or Brokers industry is in the same range as NMR (34). This means that GS’s stock grew similarly to NMR’s over the last 12 months.
NMR's SMR Rating (3) in the Investment Banks Or Brokers industry is in the same range as GS (7). This means that NMR’s stock grew similarly to GS’s over the last 12 months.
GS's Price Growth Rating (9) in the Investment Banks Or Brokers industry is somewhat better than the same rating for NMR (43). This means that GS’s stock grew somewhat faster than NMR’s over the last 12 months.
NMR's P/E Growth Rating (19) in the Investment Banks Or Brokers industry is in the same range as GS (27). This means that NMR’s stock grew similarly to GS’s over the last 12 months.
| GS | NMR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 56% | 2 days ago 48% |
| Stochastic ODDS (%) | 2 days ago 59% | 2 days ago 56% |
| Momentum ODDS (%) | N/A | 2 days ago 57% |
| MACD ODDS (%) | 2 days ago 76% | N/A |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 62% |
| TrendMonth ODDS (%) | 2 days ago 58% | 2 days ago 60% |
| Advances ODDS (%) | 8 days ago 61% | 8 days ago 64% |
| Declines ODDS (%) | 14 days ago 55% | 28 days ago 58% |
| BollingerBands ODDS (%) | 2 days ago 48% | 2 days ago 57% |
| Aroon ODDS (%) | 2 days ago 51% | 2 days ago 59% |
A.I.dvisor indicates that over the last year, NMR has been loosely correlated with GS. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if NMR jumps, then GS could also see price increases.